|
Aug 2
|
Bristol-Myers Squibb Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 1
|
Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?
|
|
Aug 1
|
Regeneron cancer bispecific rejected again; Allogene discloses trial death
|
|
Aug 1
|
Bristol-Myers Squibb (BMY) Sees Healthy Momentum in Growth Portfolio in Q2 2025
|
|
Jul 31
|
Trump Talks Tough on Drug Prices but His Demands Have Softened
|
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
|
Jul 31
|
Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs
|
|
Jul 31
|
Why Bristol-Myers Squibb (BMY) Stock Is Trading Lower Today
|
|
Jul 31
|
Economy Heating Up on PCE for June
|
|
Jul 31
|
Arm Holdings slips on guidance, AbbVie Q2 beat, Bristol-Myers outlook
|
|
Jul 31
|
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
|
|
Jul 31
|
PCE Comes in Warmer Than Expected
|
|
Jul 31
|
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q2, Full-Year Sales Guidance is Optimistic
|
|
Jul 31
|
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
|
|
Jul 31
|
Is Wall Street Bullish or Bearish on Bristol-Myers Stock?
|
|
Jul 31
|
Bristol Myers (BMY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Jul 31
|
Bristol Myers Beats Earnings Expectations. It’s Still Optimistic About New Schizophrenia Drug.
|
|
Jul 31
|
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates
|
|
Jul 31
|
Bristol Myers Squibb Cuts Full-Year Adjusted View, but Raises Revenue Expectations
|
|
Jul 31
|
Bristol-Myers Squibb shares rise as Q2 results boosted by growth portfolio
|